Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced its inclusion in the Russell 3000® and Russell 2000® Indexes, which became effective yesterday. This milestone marks a significant step …
Aclaris Therapeutics Joins Russell 3000 and Russell 2000 Indexes Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced its inclusion in both the Russell 3000® Index and the Russell 2000® Index as part of the 2025 reconstitution of …
Palvella Therapeutics Joins Russell 3000 and Russell 2000 Indexes Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) and Enactus announced the launch last week of the 2025 iTwin4Good Challenge, an international competition aimed at empowering university students to develop digital …
Bentley Systems and Enactus Launch iTwin4Good Challenge to Tackle Infrastructure Shortages Read More
WEST CHESTER, PA — QVC Group (NASDAQ: QVCGA, QVCGP) has announced the debut of its QVC and HSN channels on Philo, a live TV streaming service with approximately 1.3 million …
QVC and HSN Channels Launch on Philo, Expanding Livestream Shopping Read More
PHILADELPHIA, PA & MALVERN, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) and OrthoCellix, Inc. have announced a definitive merger agreement to combine the two companies in an all-stock transaction. The …
Carisma Therapeutics and OrthoCellix Merge to Advance Regenerative Cell Therapy for Orthopedic Diseases Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has successfully completed enrollment in the Phase 3 SELVA clinical trial of QTORIN™ 3.9% rapamycin anhydrous gel, a potential breakthrough treatment for …
Palvella Therapeutics Announces Completion of Phase 3 SELVA Trial for QTORIN Rapamycin Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has launched a Phase 1a/1b clinical program to evaluate the safety and efficacy of ATI-052, an investigational bispecific anti-TSLP/IL-4R antibody that could …
Aclaris Therapeutics Begins Phase 1a/1b Trial for Investigational Bispecific Antibody ATI-052 Read More
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) announced that its Board of Directors declared a regular quarterly dividend of $0.34 per share, payable on July 10, 2025, to shareholders …
Omega Flex Declares Quarterly Dividend of $0.34 Per Share Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the issuance of U.S. patent No. 12,329,748 by the United States Patent and Trademark Office (USPTO), providing increased protection for its …
Palvella Therapeutics Secures New Patent for QTORIN™ Rapamycin Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a Phase 2/3 pivotal confirmatory trial of OCU410ST, an innovative …
Ocugen Receives FDA Clearance for Phase 2/3 Trial of Genetic Therapy for Stargardt Disease Read More